CAS: 1234480-46-6
![6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 5,11-dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)p…](https://static.cymitquimica.com/products/IN/thumb/DA000KKY.jpg)
6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 5,11-dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-11-methyl-
CAS:1234480-46-6
Fórmula:
C24H27N7O2
Pureza:
95%
Cor e Forma:
Solid
Peso molecular:
445.5169
Ref: IN-DA000KKY
| 5mg | 191,00 € | ||
| 25mg | 189,00 € | ||
| 50mg | 228,00 € | ||
| 100mg | 534,00 € | ||
| 250mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 7 de Janeiro de 2025
XMD8-87
CAS:1234480-46-6
XMD8-87 (ACK1-B19), a TNK2 inhibitor, strongly blocks TNK2 phosphorylation and mutations in tumors.
Fórmula:
C24H27N7O2
Pureza:
97.12% - 97.61%
Cor e Forma:
Solid
Peso molecular:
445.52
Ref: TM-T3709
| 2mg | 46,00 € | ||
| 5mg | 73,00 € | ||
| 10mg | 102,00 € | ||
| 25mg | 186,00 € | ||
| 50mg | 303,00 € | ||
| 100mg | 500,00 € | ||
| 500mg | 1.210,00 € | ||
| 1mL*10mM (DMSO) | 87,00 € |
Entrega estimada em Estados Unidos, Terça-feira 14 de Janeiro de 2025
XMD8-87
CAS:1234480-46-6
XMD8-87 is a cancer drug under development by Novartis that inhibits the growth of tumor …
Fórmula:
C24H27N7O2
Pureza:
Min. 95%
Peso molecular:
445.52 g/mol
Ref: 3D-JZB48046
| 50mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 18 de Fevereiro de 2025
